Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) and CTT Pharmaceutical Holdings Inc. (OTC: CTTH) announced this morning that Aurora will be acquiring a 9.14% ownership position in CTT Pharma by a non-brokered private placement worth US$1 million 5% convertible debenture. The agreement includes the issuance of warrants enabling to Aurora to increase its ownership into the company to 42.5%.
Announced last month, Aurora Cannabis had gained the rights to six patents held by CTT Pharmaceutical Holdings that are related to cannabinoid delivery for pain management that will use sublingual wafers to deliver the benefits of medicinal cannabinoids to patients. The “Orally Dissolvable Thin Film” wafers are a patented delivery mechanism that allows cannabinoids to be delivered directly into the blood stream by dissolving into the capillaries underneath your tongue.
This investment by Aurora Cannabis will expand upon the terms of their originally decided agreement by allowing the company the exclusive rights to develop, manufacture, and distribute these products globally. The company currently owns Berlin-based Pedanious GmbH which is a leading wholesale importer, exporter, and distributor of medical grade cannabis across the European Union.
Aurora Cannabis has made headlines this year with its multi-billion dollars deal to acquire CanniMed Therapeutics Inc. and the company has a current market cap of $4.68 billion dollars.
You may be interested
Health Canada Issues Significant Changes to Industrial Hemp RegulationsEditor - August 11, 2018
Health Canada, the overseeing body in charge of industrial hemp licensing and its regulations has just issued a new class exemption for cultivators of the plant within…
CCT150 Top 5 Banking Solutions for the Cannabis and Hemp IndustriesEditor - August 10, 2018
Federally run banking institutions have been instructed to refrain from opening bank accounts with companies involved in the cannabis and hemp industries. If they do, they could…
Canopy Growth Corp. to Conduct Clinical Trials Using CBD to Treat Anxiety in AnimalsEditor - August 8, 2018
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary Canopy Health Innovations Inc. has announced this morning that they been approved by the Veterinary Drug Directorate…